SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001367644-12-000040
Filing Date
2012-08-03
Accepted
2012-08-02 18:11:45
Documents
17
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 930447
2 31-1.htm EX-31.1 10507
3 31-2.htm EX-31.2 10519
4 32-1.htm EX-32.1 5036
5 32-2.htm EX-32.2 5317
6 exhibit10_1.htm EX-10.1 243479
7 exhibit10-2.htm EX-10.2 408900
8 exhibit10-3.htm EX-10.3 41746
9 exhibit10-6.htm EX-10.6 12134
10 exhibit10-7.htm EX-10.7 57080
11 exhibit10-8.htm EX-10.8 23205
  Complete submission text file 0001367644-12-000040.txt   5529008

Data Files

Seq Description Document Type Size
12 ebs-20120630.xml EX-101.INS 654731
13 ebs-20120630.xsd EX-101.SCH 25995
14 ebs-20120630_cal.xml EX-101.CAL 53748
15 ebs-20120630_def.xml EX-101.DEF 106557
16 ebs-20120630_lab.xml EX-101.LAB 389803
17 ebs-20120630_pre.xml EX-101.PRE 241036
Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850 (301) 795-1800
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33137 | Film No.: 121004745
SIC: 2834 Pharmaceutical Preparations